Jiangsu Kanion Pharmaceutical News and Activities

Jiangsu Kanion Pharmaceutical is a company listed under the stock ticker 600557 (CN).

View the org chart displaying its 18 main executives

Most searched biographies at Jiangsu Kanion Pharmaceutical

• Yongchun Yang, General Manager
• Kaixian Chen, Independent Director
• Chen Yanxi, Independent Director

Popular executive movements at Jiangsu Kanion Pharmaceutical

• Qing Li has joined the company as Chief Financial Officer  (posted on January 21 2026).
• Suocheng Jiang, Chief Financial Officer, has left the company  (posted on January 21 2026).

Create your alert
to follow the executive moves at Jiangsu Kanion Pharmaceutical.

Jiangsu Kanion Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Jiangsu Kanion Pharmaceutical

Social media about Jiangsu Kanion Pharmaceutical

• Jiangsu Kanion Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jiangsu Kanion Pharmaceutical on LinkedIn, X (Twitter) & YouTube